The South Africa hemodialysis & peritoneal dialysis market size to be valued at USD 847.2 million by 2025 and is expected to grow at a compound annual growth rate (CAGR) of 7.1% during the forecast period. The rising incidence of kidney failure and chronic renal dysfunction is expected to promote market growth over the forecast period. The Clinical Kidney Journal states that the prevalence of chronic kidney disease in Africa was pegged at 13.9% in 2016.
增加高血压的患病率和迪亚布etes is anticipated to drive the need for dialysis as these diseases could result in kidney dysfunction. South Africa has a large patient population with inadequate funding and healthcare facilities that are not too well developed. This provides lucrative growth opportunities to market players in this region. Transplantation and dialysis are the two options available to patients suffering from kidney failure or severe kidney damage. There are very few kidney donors in the region and this situation is unlikely to change in the coming years, thereby propelling the demand for dialysis.
The latest dialysis machines are designed to enhance patient usability through easy setup, treatment, and cleanup. Medtronic launched a new portable dialysis machine in July 2017, which is likely to help patients in remote areas. Advancements such as these are making the procedure simple, less painful, convenient, and time-saving.
The rise in the incidence of CKD (chronic kidney diseases) and ESRD (End Stage Renal Diseases) is a major factor driving the demand for dialysis. Moreover, new healthcare funding channels improved healthcare systems, and the introduction of technological innovations in dialysis devices are all projected to increase the demand for dialysis devices and their market.
The increasing availability of qualified nephrologists led to many people receiving renal care in the region. Furthermore, to meet the growing need for renal care in developing markets, investors are concentrating their efforts on expanding the number of renal treatment centers in the region. Therefore, there is expansion because of the access to low-cost centers in these areas.
Furthermore, the approval of regulatory bodies for the launch of innovative products and consumables, public sector participation in the prevention and control of kidney diseases, and collaborative effort by various organizations to provide efficient dialysis services in niche areas, are expected to boost the market growth during the forecast period.
Heart disease and vascular access problems including nausea, internal bleeding, anemia, hernia, hepatitis B and C, and low blood pressure are the primary reasons for death in dialysis patients. These factors make patients scared of treatment, hampering the market growth.
Key players are increasingly focusing on the implementation of agreements with domestic players and geographic expansions to raise their market presence. Moreover, government funding, the advancement of home dialysis, and the increasing number of dialysis centers are all aiding dialysis treatment and are expected to provide an opportunity for growth during the forecast period.
On the basis of type, the South Africa hemodialysis & peritoneal dialysis market is segmented into hemodialysis and peritoneal dialysis. As of 2016, hemodialysis dominated the market and is anticipated to retain its dominance through 2025. The segment is poised to exhibit a CAGR of over 7.0% during the forecast period. Hemodialysis is an alternative treatment option for people who failed to receive a kidney transplant. In 2015, the highest number of patients were registered at Gauteng, followed by KwaZulu-Natal and the Western Cape.
Peritoneal dialysis is also expected to witness lucrative growth owing to rising demand for the treatment method amongst neonates and children. Furthermore, the higher applicability of this technique in home-based services is promoting the growth of the segment.
On the basis of product, the market is segmented into devices, consumables, and services. The services segment held the dominant share owing to an increase in the adoption of home-based dialysis and the development of new treatment centers. Africa has few dialysis centers due to a shortage of water supply, poor electricity supply, and the high cost of dialysis machines.
设备进一步划分为机器,印度zers, water treatment systems, and others. Dialyzers dominated the market space as of 2016, as it is the primary equipment required for the procedure. Consumables are sub-segmented into bloodlines, concentrates and catheters, and others; concentrates dominated this segment owing to routine and frequent purchase of the product.
On the basis of end use, the market is classified into home-based and hospital-based. Hospital-based dialysis is the largest segment due to the availability of professionals who can address any complications that arise during dialysis and help achieve better results. However, home-based dialysis is anticipated to witness lucrative growth over the forecast period. This can be attributed to a number of factors such as an increase in the development of small and automated products for home use, a rise in the number of individuals requiring daily dialysis, availability of skilled personnel to provide training on self-dialysis, and initiatives by market participants for raising awareness about home dialysis.
Fresenius Medical Care AG & Co. KGaA; B.Braun Avitum AG; NIPRO Medical Corporation; DaVita, Inc.; and Baxter are key players in this region. The market is dominated by a handful of participants, who account for a majority share. They are engaged in growth strategies such as alliances, product differentiation, and diversification, and broadening marketing and distribution channels to increase the reach of their products and gain a competitive edge.
例如,2016年7月,达维塔宣布upport for the Dialysis Patient Demonstration Act. The initiative works to provide better patient care and give power not only to patients and taxpayers but also to physicians, thereby helping in making the healthcare system more efficient.
In March 2022, B. Braun acquired Intermedt Medizin & Technik GmbH, which is a specialist in manufacturing dialysis concentrates. This has resulted in B. Braun Avitum division finishing its wide brand portfolio as a systems producer for extracorporeal blood therapy (dialysis)
In March 2022, Nipro Medical Corporation, a prominent manufacturer, and provider of vascular products, introduced a second-generation Cronus HP PTA balloon catheter. It constitutes a high pressure and can easily be utilised for better vascular and renal divisions during the dialysis process
In April 2022, DaVita Inc., a renowned kidney care provider agreed for a collaboration with Rockwell Medical, Inc., a biopharmaceutical focused on revolutionizing the treatment of anaemia. This collaboration with DaVita is intended to assist Rockwell Medical to maintain a more solid financial position so that it continues to supply facilities to its partners and provide service to patients with dialysis
Report Attribute |
Details |
Market size value in 2020 |
USD 600.3 million |
Revenue forecast in 2025 |
USD 847.2 million |
Growth Rate |
CAGR of 7.1% from 2017 to 2025 |
Base year for estimation |
2016 |
Historical data |
2014 - 2015 |
Forecast period |
2017 - 2025 |
Quantitative units |
Revenue in USD million and CAGR from 2017 to 2025 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Type, product, end use |
Country scope |
South Africa |
Key companies profiled |
Fresenius Medical Care AG & Co. KGaA; B.Braun Avitum AG; NIPRO Medical Corporation; DaVita, Inc.; Baxter Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs.Explore purchase options |
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research, Inc. has segmented the South Africa hemodialysis & peritoneal dialysis market report on the basis of type, product, and end use:
Type Outlook (Revenue, USD Million, 2014 - 2025)
Hemodialysis
Peritoneal dialysis
Product Outlook (Revenue, USD Million, 2014 - 2025)
Devices
Consumables
Services
End-use Outlook (Revenue, USD Million, 2014 - 2025)
Hospital-based
Home-based
b.The global South Africa hemodialysis & peritoneal dialysis market was estimated at USD 561.3 million in 2019 and is expected to reach USD 600.3 million in 2020.
b.The global South Africa hemodialysis & peritoneal dialysis market is expected to grow at a compound annual growth rate of 7.1% from 2017 to 2025 to reach USD 847.2 million by 2025.
b.The South Africa hospital-based segment dominated the market and was valued at USD 450.2 million in 2019. This is attributable to the availability of professionals in hospitals to address any complications that arise during dialysis therapy and due to the availability of reimbursement policies.
b.Some key players operating in the South Africa hemodialysis & peritoneal dialysis market includes Fresenius Medical Care AG & Co. KGaA; B.Braun Avitum AG; NIPRO Medical Corporation; DaVita, Inc.; and Baxter Inc.
b.Key factors that are driving the market growth include rising incidence of kidney failure and chronic renal dysfunction as well as technological advancements.
"The quality of research they have done for us has been excellent."